Home/Pipeline/TCR-T Programs

TCR-T Programs

Solid Tumors

Pre-clinicalResearch Stage

Key Facts

Indication

Solid Tumors

Phase

Pre-clinical

Status

Research Stage

Company

Genscript Biotech

About Genscript Biotech

Founded in 2002 and publicly listed on the Hong Kong Stock Exchange, Genscript Biotech has evolved from a pioneering gene synthesis service provider into a fully integrated global biotechnology platform. The company operates through three core segments: Life Science Services and Products, Biologics Contract Development and Manufacturing (CDMO), and its own innovative cell therapy pipeline. Its strategic focus includes leveraging its strong R&D foundation to advance proprietary cell therapies while expanding its global CDMO footprint to capture the booming biologics and cell/gene therapy market.

View full company profile

Therapeutic Areas

Oncology Hematological Malignancies Solid Tumors

Other Solid Tumors Drugs

Drug	Company	Phase	Status
GSK4362676	GSK plc	Phase 1	Active
ABBV-154	AbbVie	Phase 1	Active
TAK-981	Takeda Pharmaceutical	Phase 1/2	Active
TAK-676	Takeda Pharmaceutical	Phase 1	Active
TAK-573	Takeda Pharmaceutical	Phase 1	Active
TAK-164	Takeda Pharmaceutical	Phase 1	Active
SHR-1316	Jiangsu Hengrui Medicine	Phase 1/2	Active
BAY 2927088	Bayer	Phase 1	Active
ASP1929	Astellas Pharma	Phase 2	Active
IBI188	Innovent Biologics	Phase 1	Active
Bispecific Antibody	Akeso	Phase 1/2	Active
CSPC-DM02	CSPC Pharmaceutical Group Limited	Phase 2	Active